Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of cancer research that can provide new insights into gene function as well as new targets for drug development. Most methods for prioritizing mutations rely primarily on frequency-based criteria, where a gene is identified as having a driver mutation if it is altered in significantly more samples than expected according to a background model. Although useful, frequency-based methods are limited in that all mutations are treated equally. It is well known, however, that some mutations have no functional consequence, while others may have a major deleterious impact. The spatial pattern of mutations within a gene provides further insight into their ...
Summary: Large-scale cancer sequencing studies of patient cohorts have statistically implicated many...
Abstract Cancer sequencing projects are now measuring somatic muta-tions in large numbers of cancer ...
Genomic sequence mutations can be pathogenic in both germline and somatic cells. Several authors hav...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Motivation: The number of missense mutations being identified in cancer genomes has greatly increase...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
The availability of the human genome sequence and progress in sequencing and bioinformatic technolog...
Background: Identifying cancer “driver” genes (CDG) is a crucial step in cancer genomic toward the a...
The significant improvements in throughput and quality of DNA sequencing technology have revolutioni...
The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, gen...
Summary: Large-scale cancer sequencing studies of patient cohorts have statistically implicated many...
Abstract Cancer sequencing projects are now measuring somatic muta-tions in large numbers of cancer ...
Genomic sequence mutations can be pathogenic in both germline and somatic cells. Several authors hav...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
Motivation: Identifying and prioritizing somatic mutations is an important and challenging area of c...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
AbstractThe availability of the human genome sequence and progress in sequencing and bioinformatic t...
Motivation: The number of missense mutations being identified in cancer genomes has greatly increase...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
The availability of the human genome sequence and progress in sequencing and bioinformatic technolog...
Background: Identifying cancer “driver” genes (CDG) is a crucial step in cancer genomic toward the a...
The significant improvements in throughput and quality of DNA sequencing technology have revolutioni...
The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, gen...
Summary: Large-scale cancer sequencing studies of patient cohorts have statistically implicated many...
Abstract Cancer sequencing projects are now measuring somatic muta-tions in large numbers of cancer ...
Genomic sequence mutations can be pathogenic in both germline and somatic cells. Several authors hav...